We are live on ! Find out more
ZCM

Zebra Capital Management Portfolio holdings

AUM $20M
1-Year Est. Return 2.24%
This Fund
S&P 500
This Quarter Est. Return
+18.5%
1 Year Est. Return
+2.24%
3 Year Est. Return
+142.1%
5 Year Est. Return
+107.07%
10 Year Est. Return
+252.16%
AUM
$90.8M
AUM Growth
+$12M
Cap. Flow
+$4.91M
Cap. Flow %
5.41%
Top 10 Hldgs %
18.38%
Holding
278
New
115
Increased
17
Reduced
37
Closed
109

Top Buys

Rank Stock Value
1
EBS icon
Emergent Biosolutions
EBS
+$2.15M
2
KELYA icon
Kelly Services Class A
KELYA
+$1.94M
3
ESGR
Enstar Group
ESGR
+$1.61M
4
LCII icon
LCI Industries
LCII
+$1.56M
5
UPBD icon
Upbound Group
UPBD
+$1.33M

Top Sells

Rank Stock Value
1
WDFC icon
WD-40
WDFC
+$1.47M
2
CORT icon
Corcept Therapeutics
CORT
+$1.23M
3
VCYT icon
Veracyte
VCYT
+$1.22M
4
CSTL icon
Castle Biosciences
CSTL
+$1.03M
5
CDMO
Avid Bioservices, Inc. Common Stock
CDMO
+$965K

Sector Composition

Rank Sector Weight
1 Healthcare 20.12%
2 Industrials 15.8%
3 Financials 14.75%
4 Consumer Discretionary 13.38%
5 Technology 12.63%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HIBB
276
DELISTED
Hibbett, Inc. Common Stock
HIBB
– –
-5,901
Closed -$273K
QADA
277
DELISTED
QAD Inc.
QADA
– –
-8,839
Closed -$559K
MNR
278
DELISTED
Monmouth Real Estate Investment Corp
MNR
– –
-41,763
Closed -$723K
8 9 10 11
12

Similar funds

CM
Cartica Management Washington, District of Columbia $20.9M AUM 14.51% 1-Year Est. Return
NPAM
Noble Path Asset Management New York $14.6M AUM 3.07% 1-Year Est. Return
6C
6elm Capital New York $33.3M AUM 34.31% 1-Year Est. Return
SCU
Spinnaker Capital (UK) London England, United Kingdom $5.4M AUM 7.99% 1-Year Est. Return
FFG
Ford Financial Group Fresno, California $2.36M AUM 7.29% 1-Year Est. Return
KE
KLP Enterprises Branford, Connecticut $1.97M AUM
GFT
Gilfoyle Foundation Trust New Fairfield, Connecticut $100 AUM
CCM
CTC Capital Management Chicago, Illinois $47.8M AUM 5.18% 1-Year Est. Return

Zebra Capital Management's Q1 2021 Portfolio in Review

As of Q1 2021, Zebra Capital Management held 278 positions worth $90.8M, up 15% from $78.8M the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Zebra Capital Management deployed $4.91M of net new capital in Q1 2021, opening 115 new positions and adding to 17 existing holdings. Its largest new stake was Emergent Biosolutions: 20,957 shares worth $1.95M.

By sector, the portfolio is most concentrated in Healthcare at 20% of assets, down from 21% a quarter earlier, followed by Industrials and Financials.

On the sell side, the largest reduction was Veracyte, an estimated $1.22M trimmed.

  • Zebra Capital Management's largest Q1 2021 buy was Emergent Biosolutions: 20,957 shares worth $1.95M.
  • Zebra Capital Management added most to Rush Enterprises Class A in Q1 2021, an estimated $819K increase.
  • Zebra Capital Management's biggest Q1 2021 reduction was Veracyte, cutting an estimated $1.22M.
  • Zebra Capital Management fully exited WD-40 in Q1 2021, selling an estimated $1.47M.
  • Zebra Capital Management's ten largest holdings make up 18% of its $90.8M portfolio in Q1 2021.
  • Zebra Capital Management opened 115 new positions and closed 109 in Q1 2021.
  • Zebra Capital Management's portfolio value rose 15% quarter-over-quarter to $90.8M.

Based on Zebra Capital Management's 13F filing for Q1 2021, filed 17 May 2021.